Tuberculosis (TB) is an umbrella term for infection with mycobacterium tuberculosis, an organism which has existed alongside humans for thousands of years, with DNA evidence...
Added 6 months ago Drug news
The FDA has announced its approval of PaMZ (pretomanid), from TB Alliance, a new drug developed to treat Extensively Drug-Resistant Tuberculosis (XDR-TB)...
Added 9 months ago Drug news
MTB-RIF/INH test is used to detect antibiotic resistance mutations in the Mycobacterium tuberculosis
Roche secured the CE-IVD mark for its Cobas MTB-RIF/INH test, an assay used to detect antibiotic resistance mutations in the...
Added 1 year ago Drug news
M72/AS01E vaccine in an ongoing Phase IIb trial reduced the incidence of pulmonary tuberculosis disease.- GSK
GSK and Aeras reported that GSK’s M72/AS01E candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.
Access the comprehensive Learning Zone for moderate to severe asthma. Containing details about pathophysiology, a complete overview of asthma and daily reports from ERS Congress 2019.
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.
Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.
This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults.
Added 4 years ago
This guideline provides guidance on the principles and recommendations for nutritional care and support of patients with TB as part...
Added 7 years ago
Tuberculosis remains a global health problem, with an estimated 10.4 million cases and 1.8 million deaths resulting from the disease in 2015. The most lethal and disabling form of tuberculosis is tuberculous meningitis...
Added 2 years ago
Patients with loculated tuberculous pleurisy (TBP) treated with urokinase suffer less from residual pleural thickening (RPT) than those treated with simple drainage.
Added 3 years ago
Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase...
Added 4 years ago
- Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- Registration required
- Subscription fee